# Citius Oncology, Inc.: Form 8-K, filed Dec 27, 2024

- Company: [Citius Oncology, Inc.](/companies/ctor.md) (CIK 1851484)
- Form: 8-K
- Filed: 2024-12-27
- Accepted by EDGAR: Dec 27, 2024, 17:10 ET
- Period: 2024-12-27
- Accession: 0001213900-24-113159
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1851484/000121390024113159/ea0226165-8k_citius.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1851484/000121390024113159/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1851484/000121390024113159/ea0226165-8k_citius.htm

Filed Dec 27, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-113159. Last ingested by Listed: Nov 4, 2026, 17:46 ET. No prices; not investment advice.
